AGP Executive Report
Last update: 4 minutes agoPsychedelic Research & Addiction: Ibogaine—used for centuries in Gabon’s Bwiti ceremonies—is back in the spotlight as U.S. policy shifts and funding accelerate psychedelic drug-development, though the substance remains investigational and still carries serious risks. Gabon Energy & Oil Sector: Record Resources says it has sold non-core rights tied to a Lake Temiskaming property, while doubling down on its Gabon oil and gas focus, including the Ngulu block and the Loba discovery. AI in Healthcare: Malawi hospitals report major drops in child deaths after deploying IMPALA, an AI patient monitoring system that flags deterioration early in low-resource wards. Dengue Vaccine Trials in Africa: KNUST joins the DENSTAR project to help fast-track a single-dose dengue vaccine, with Phase III trials planned across sub-Saharan Africa. AI Browser Rollout: Google expands “Ask Gemini in Chrome” to Kenya, Nigeria, South Africa, and includes Gabon among 55 supported locales. Electricity Access Across Africa: Mission 300 says it has connected over 50 million people to power across 40 countries, aiming to reach 300 million by 2030. Digital Rights & Elections: A new analysis warns that digital disinformation rules can be misused for surveillance and internet shutdowns, citing cases including Gabon.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
